Sort
39,280 grants matching “leukemia”
PEDIATRIC CHTN--AIDS CANCER RESEARCH
$844,379Research Inst Nationwide Children'S Hosp · U01 · FY2001 · CA
Impact of Infection and Inflammation on Primitive Hematopoiesis
$844,190Katherine Yudeh King · Baylor College Of Medicine · R35 · FY2024 · HL
Molecular epidemiology of acute lymphoblastic leukemia in children with Down syndrome
$843,979Karen R Rabin · Baylor College Of Medicine · R01 · FY2023 · CA
Lymphoma Disease Discovery and Definition
$843,916Elaine Jaffe · Division Of Clinical Sciences - Nci · ZIA · FY2016 · CA
Cancer Gene Discovery to Identify Targetable Targets
$843,904Carlo M Croce · Ohio State University · R35 · FY2021 · CA
Biological Functions of Chromosomal Proteins
$842,732Michael Bustin · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Epigenetic control during embryogenesis
$842,607Kathrin Muegge · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Regulation And Function Of Retroelements
$842,295Henry L. Levin · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2017 · HD
GrowthDifferentiation Factors in Organogenesis
$842,150Alan Perantoni · Basic Sciences · Z01 · FY2007 · CA
Molecular Diagnosis and Prognosis in Aggressive Lymphoma
$841,820Lisa Rimsza · Mayo Clinic Arizona · U01 · FY2015 · CA
Core--Radiochemistry Laboratory
$841,566Joseph G Rajendran · Fred Hutchinson Cancer Research Center · P01 · FY2009 · CA
Combining Targeted RIT and Synergistic Novel Agents to Eradicate AML
$841,070Johnnie Jose Orozco · Fred Hutchinson Cancer Center · R37 · FY2023 · CA
Next Generation Therapies for Fertility Preservation in Male Cancer Patients
$839,570Kyle E Orwig · Magee-Women'S Res Inst And Foundation · R01 · FY2020 · HD
Cancer Mortality among Military Participants at U.S. Nuclear Weapons Tests
$839,275John Dunning Boice · Vanderbilt University · U01 · FY2010 · CA
Preventing GVHD by inhibition of alloantigen presentation in the gut
$839,267Geoffrey Roger Hill · Fred Hutchinson Cancer Center · R01 · FY2024 · HL
Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children
$838,928Carlos O Esquivel · Stanford University · U01 · FY2018 · AI
Predicting Chemotherapy-Induced Mucositis with Genetic and Clinical Factors
$838,366Elizabeth Ann Coleman · Univ Of Arkansas For Med Scis · RC2 · FY2009 · NR
Specific Adoptive Immunotherapy of AML with Engineered CD8+ T Cells
$838,209Philip D Greenberg · Fred Hutchinson Cancer Research Center · P01 · FY2018 · CA
HDAC Inhibition to prevent GVHD
$838,093Pavan Reddy · University Of Michigan At Ann Arbor · P01 · FY2010 · CA
Increased sensitivity of minimal residual disease monitoring using peripheral blood in pediatric patients with acute lymphoblastic leukemia
$837,994Rolf Muller · Biofluidica, Inc · R44 · FY2019 · CA
A nonhuman primate model of stem cell transplantation to understand determinants of post-transplant SIV clearance
$837,954Jonah B. Sacha · Oregon Health & Science University · R01 · FY2022 · AI
Biological Functions of Chromosomal Proteins
$837,688Michael Bustin · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
GM-CSF/sargramostim treatment to improve cognition in Down syndrome
$836,914Huntington Potter · University Of Colorado Denver · R61 · FY2022 · AG
A novel glutaminase-free mammalian asparaginase with minimized immunogenicity to enable expanded use in cancer therapy
$836,804Amanda M Schalk · Enzyme By Design, Inc. · R44 · FY2022 · CA
High Resolution Multiplexed DNA reverse-SSO Typing Assay
$836,774Jar-How Lee · One Lambda, Inc. · R44 · FY2006 · AI